Jingmin Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jingmin Cheng has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Yongxiang Yang
Department of Neurosurgery, The General Hospital of Western Theater Command
4 shared publicationsKexia Fan
Department of Neurosurgery, The General Hospital of Western Theater Command
3 shared publicationsXiansong Zhu
Department of Neurosurgery, The General Hospital of Western Theater Command
3 shared publicationsDongbo Zou
Department of Neurosurgery, The General Hospital of Western Theater Command
2 shared publicationsTao Yang
Department of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, China
2 shared publications- Tao Yang
Department of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, China
2 shared publications
Latest Publications
- Open Access
- 3 March 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1763619
Clinical differences between elderly and non-elderly chronic subdural hematoma patients
Objective: Chronic subdural hematoma (CSDH) is a common disease in elderly population, which can also be seen in young and middle-aged individuals. In order to understand the clinical features of this disease deeply, we conducted this retrospective study to clarify the clinical differences between elderly and non-elderly CSDH patients. Methods: According to the inclusion and exclusion criteria, 268 elderly CSDH patients and 87 non-elderly CSDH patients were recruited from January 2015 to December 2024 in our cohort. The collected data and compared parameters including baseline clinical features and radiological outcomes of hematoma within 24 h of hospital admission, as well as the treatment method and clinical outcome of elderly and non-elderly CSDH patients. Results: Compared to non-elderly CSDH patients, female was more frequent, the traumatic events were less common, and the history of taking anticoagulants and antiplatelet drugs were more common in elderly CSDH patients (all P < 0.05). Moreover, the hematoma was thicker and larger, the usage of atorvastatin was more common, the recurrence rate was higher, and the mean hospital stay was longer in elderly CSDH patients than in non-elderly CSDH patients (all P < 0.05). Conclusion: Elderly CSDH patients were less likely to have the traumatic events and more likely to have the history of taking anticoagulants/antiplatelet drugs, who were also owing the higher rate of using atorvastatin and hematoma recurrence, compared to non-elderly CSDH patients.
- 3 March 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1763619
Open AccessClinical differences between elderly and non-elderly chronic subdural hematoma patients
Objective: Chronic subdural hematoma (CSDH) is a common disease in elderly population, which can also be seen in young and middle-aged individuals. In order to understand the clinical features of this disease deeply, we conducted this retrospective study to clarify the clinical differences between elderly and non-elderly CSDH patients. Methods: According to the inclusion and exclusion criteria, 268 elderly CSDH patients and 87 non-elderly CSDH patients were recruited from January 2015 to December 2024 in our cohort. The collected data and compared parameters including baseline clinical features and radiological outcomes of hematoma within 24 h of hospital admission, as well as the treatment method and clinical outcome of elderly and non-elderly CSDH patients. Results: Compared to non-elderly CSDH patients, female was more frequent, the traumatic events were less common, and the history of taking anticoagulants and antiplatelet drugs were more common in elderly CSDH patients (all P < 0.05). Moreover, the hematoma was thicker and larger, the usage of atorvastatin was more common, the recurrence rate was higher, and the mean hospital stay was longer in elderly CSDH patients than in non-elderly CSDH patients (all P < 0.05). Conclusion: Elderly CSDH patients were less likely to have the traumatic events and more likely to have the history of taking anticoagulants/antiplatelet drugs, who were also owing the higher rate of using atorvastatin and hematoma recurrence, compared to non-elderly CSDH patients.
- Open Access
- 21 August 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (8) , e70711
The Prognostic Value of Inflammatory Indexes in Patients With Severe Traumatic Brain Injury
Objective: This study aims to investigate whether the inflammatory indexes including neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), lymphocyte to monocyte ratio (LMR), and systemic inflammatory indexes (SIIs) can prognosis the outcome of patients with severe traumatic brain injury (sTBI).Methods: A total of 118 sTBI patients were retrospectively recruited from June 2015 to June 2024. First, the clinical data including baseline clinical features, hematological indexes at 1/3/7 days after hospital admission, were collected, and the Glasgow Coma Scale (GCS) at 3 months after discharge was recorded. Then, the absolute value of SII, NLR, PLR and LMR was calculated, and the prognostic value of them was further analyzed via comparative, relevant, and regression statistical methods.Results: Compared to sTBI patients in the favorable outcome group, the absolute value of white blood cell (WBC) and neutrophil at 1/3/7 days, and the absolute value of monocyte at 1 day and NLR at 3 days after admission was higher in sTBI patients of the unfavorable outcome group. ROC curve and multivariate logistic regression analysis indicated that NLR at 3 days after admission was an independent prognostic factor for GOS in patients with sTBI.Conclusions: NLR at 3 days after admission might be a new, accurate, and objective inflammatory index, which had prognostic value in the clinical outcome prediction for patients with sTBI.
- 21 August 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (8) , e70711
Open AccessThe Prognostic Value of Inflammatory Indexes in Patients With Severe Traumatic Brain Injury
Objective: This study aims to investigate whether the inflammatory indexes including neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), lymphocyte to monocyte ratio (LMR), and systemic inflammatory indexes (SIIs) can prognosis the outcome of patients with severe traumatic brain injury (sTBI).Methods: A total of 118 sTBI patients were retrospectively recruited from June 2015 to June 2024. First, the clinical data including baseline clinical features, hematological indexes at 1/3/7 days after hospital admission, were collected, and the Glasgow Coma Scale (GCS) at 3 months after discharge was recorded. Then, the absolute value of SII, NLR, PLR and LMR was calculated, and the prognostic value of them was further analyzed via comparative, relevant, and regression statistical methods.Results: Compared to sTBI patients in the favorable outcome group, the absolute value of white blood cell (WBC) and neutrophil at 1/3/7 days, and the absolute value of monocyte at 1 day and NLR at 3 days after admission was higher in sTBI patients of the unfavorable outcome group. ROC curve and multivariate logistic regression analysis indicated that NLR at 3 days after admission was an independent prognostic factor for GOS in patients with sTBI.Conclusions: NLR at 3 days after admission might be a new, accurate, and objective inflammatory index, which had prognostic value in the clinical outcome prediction for patients with sTBI.
- Open Access
- 31 October 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1440247
Clinical features of pituitary carcinoma: analysis based on a case report and literature review
Introduction: Pituitary carcinoma (PC) is an extremely rare tumor of the adenohypophysis, which manifests as craniospinal dissemination and/or systemic metastasis. The diagnosis of PC is particularly difficult, as the clinical diagnosis only can be made after the metastasis is found. Owing to the complex diagnostic process and less effective treatments, the clinical prognosis of PC is usually very poor. Hence, it is of great significance to illustrate the diagnosis and treatment course of PC.Methods: In this case report, we described a 48-year-old male patient who was diagnosed with pituitary adenoma (PA) initially and then was diagnosed with PC eventually after spinal cord metastasis was found, and we illustrated the treatment course as well. Furthermore, we summarized all the published case reports until now and provided a comprehensive review of the diagnosis, treatment, prediction, and clinical outcome of PC.Results and Conclusions: We found that most PC patients had adrenocorticotropic hormone/prolactin (ACTH/PRL)-secreting tumors, Ki-67 ≥ 10%, and P53 positivity, which may have the potential to predict the transformation from PA to PC; surgery excision combined with temozolomide (TMZ) and radiotherapy is helpful to prolong the survival of PC patients.
- 31 October 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1440247
Open AccessClinical features of pituitary carcinoma: analysis based on a case report and literature review
Introduction: Pituitary carcinoma (PC) is an extremely rare tumor of the adenohypophysis, which manifests as craniospinal dissemination and/or systemic metastasis. The diagnosis of PC is particularly difficult, as the clinical diagnosis only can be made after the metastasis is found. Owing to the complex diagnostic process and less effective treatments, the clinical prognosis of PC is usually very poor. Hence, it is of great significance to illustrate the diagnosis and treatment course of PC.Methods: In this case report, we described a 48-year-old male patient who was diagnosed with pituitary adenoma (PA) initially and then was diagnosed with PC eventually after spinal cord metastasis was found, and we illustrated the treatment course as well. Furthermore, we summarized all the published case reports until now and provided a comprehensive review of the diagnosis, treatment, prediction, and clinical outcome of PC.Results and Conclusions: We found that most PC patients had adrenocorticotropic hormone/prolactin (ACTH/PRL)-secreting tumors, Ki-67 ≥ 10%, and P53 positivity, which may have the potential to predict the transformation from PA to PC; surgery excision combined with temozolomide (TMZ) and radiotherapy is helpful to prolong the survival of PC patients.
- Open Access
- 17 October 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1453629
The clinical differences between traumatic and NOS chronic subdural hematoma
Objective: Chronic subdural hematoma (CSDH) is a common neurologic disorder with increasing incidence, which can be preceded by head trauma or occur in the absence of trauma. In order to deeply understand the clinical characteristics of this disease, we conducted this retrospective study to explore the clinical differences between traumatic and not otherwise specified (NOS) CSDH.Methods: According to the inclusion and exclusion criteria, 168 traumatic CSDH patients and 133 NOS CSDH patients were recruited from January 2015 to October 2023 in our cohort. The collected data and compared parameters including baseline clinical features and radiological outcomes of hematoma within 24 h of hospital admission, as well as the treatment method and clinical outcome of traumatic and NOS CSDH patients.Results: Compared to NOS CSDH patients, the average age was younger, epilepsy was more frequent, asymptomatic cases were more common, and the taking of anticoagulants and antiplatelet drugs were rarer in traumatic CSDH patients (all P < 0.05). However, no differences were found in the radiological presentations of hematoma at admission, the treatment methods and clinical outcomes of traumatic and NOS CSDH patients (all P > 0.05).Conclusion: Traumatic CSDH patients were more likely to be asymptomatic or have seizures, while NOS CSDH were more common in elder people and in individuals with the history of taking anticoagulants and antiplatelet drugs. The treatment methods and clinical outcomes were similar in traumatic and NOS CSDH patients.
- 17 October 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1453629
Open AccessThe clinical differences between traumatic and NOS chronic subdural hematoma
Objective: Chronic subdural hematoma (CSDH) is a common neurologic disorder with increasing incidence, which can be preceded by head trauma or occur in the absence of trauma. In order to deeply understand the clinical characteristics of this disease, we conducted this retrospective study to explore the clinical differences between traumatic and not otherwise specified (NOS) CSDH.Methods: According to the inclusion and exclusion criteria, 168 traumatic CSDH patients and 133 NOS CSDH patients were recruited from January 2015 to October 2023 in our cohort. The collected data and compared parameters including baseline clinical features and radiological outcomes of hematoma within 24 h of hospital admission, as well as the treatment method and clinical outcome of traumatic and NOS CSDH patients.Results: Compared to NOS CSDH patients, the average age was younger, epilepsy was more frequent, asymptomatic cases were more common, and the taking of anticoagulants and antiplatelet drugs were rarer in traumatic CSDH patients (all P < 0.05). However, no differences were found in the radiological presentations of hematoma at admission, the treatment methods and clinical outcomes of traumatic and NOS CSDH patients (all P > 0.05).Conclusion: Traumatic CSDH patients were more likely to be asymptomatic or have seizures, while NOS CSDH were more common in elder people and in individuals with the history of taking anticoagulants and antiplatelet drugs. The treatment methods and clinical outcomes were similar in traumatic and NOS CSDH patients.
- 1 July 2010
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 294 (1-2) , 23-28
Development of a rat model for studying blast-induced traumatic brain injury
- 1 July 2010
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 294 (1-2) , 23-28
Development of a rat model for studying blast-induced traumatic brain injury